Evidence map›Paper›PMID 32693803›Full record

ArticleRespiratory research2020

LPS aggravates lung inflammation induced by RSV by promoting the ERK-MMP-12 signaling pathway in mice.

Shenglin Chen, Jun Xie, Keting Zhao, Luo Ren, Yu Deng, Xiaohong Xie, Shiyi Chen, Hongmei Xu, Xiaoru Long, Enmei Liu

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shenglin ChenPediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Jun XiePediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Keting ZhaoPediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Luo RenPediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Yu DengLijia respiratory Department, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, P. R. China.
Xiaohong XieLijia respiratory Department, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, P. R. China.
Shiyi ChenPediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China.
Hongmei XuDepartment of Infection, Children's Hospital of Chongqing Medical University, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, 400014, P. R. China.
Xiaoru LongPediatric Research Institute, Children's Hospital of Chongqing Medical University, Chongqing, China. 2387207074@qq.com.ORCID http://orcid.org/0000-0002-0803-3208
Enmei LiuLijia respiratory Department, Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders; China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, 400014, P. R. China. emliu186@126.com.
China International Science and Technology Cooperation · CNChildren's Hospital of Chongqing Medical University · CNChongqing University · CN

Funding

the National Natural Science Foundation of China 81600005the National Natural Science Foundation of China 81670011the National Natural Science Foundation of China 81800009
6 · The paper itself

Abstract

backgroundRSV can lead to persistent airway inflammation and airway hyperresponsiveness (AHR), and is intimately associated with childhood recurrent wheezing and asthma, but the underlying mechanisms remain unclear. Lipopolysaccharide (LPS) is also implicated in the onset and exacerbation of asthma. However, whether inhalation of LPS can boost airway inflammation induced by RSV is not clear. In this study, we utilized an LPS- and RSV-superinfected mouse model to explore underlying pathogenesis.

methodsMice were infected with RSV on day 0 and inoculated with LPS from day 35 to day 41, samples were collected on day 42. Inflammatory cells, lung histopathology and AHR were measured. Cytokines were detected by ELISA and ERK, JNK, p38 was determined by western blot. MMP408, PD98059, SP600125 and SB203580 were used to inhibit MMP-12, ERK, JNK and p38 respectively.

resultsLPS exposure superimposed on RSV-infected lungs could lead to more vigorous cellular influx, lung structures damage, augmented AHR and higher MMP-12 levels. Inhibition of MMP-12 or ERK signaling pathway in vivo both diminished LPS-driven airway inflammation and AHR.

conclusionsExposure to LPS in RSV-infected mice is associated with enhanced increases in ERK-MMP-12 expression that translates into increased lung inflammation and AHR. These findings contribute novel information to the field investigating the onset of post-RSV bronchiolitis recurrent wheezing as a result of LPS exposure.

Indexed as

Respiratory Syncytial VirusesAnimalsBronchial HyperreactivityEnzyme InhibitorsFemaleInflammationLipopolysaccharidesLungMAP Kinase Signaling SystemMatrix Metalloproteinase 12MiceMice, Inbred BALB CRespiratory Syncytial Virus InfectionsEnzyme InhibitorsLipopolysaccharidesmatrix metallopeptidase 12, mouseMatrix Metalloproteinase 12AHRLPSLung inflammationMMP-12RSV

Identifiers

PMID32693803
PMCPMC7372760
OpenAlexW3044009963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.